Breaking News on Contract Research, Manufacturing & Clinical Trials

Library > Technical Papers

Blinding Techniques for Inhaler Devices - Development of a Novel Blinding Methodology for a Market Leading DPI

Almac Group | 15-Jan-2013 | PDF Case study
Blinding inhalers for use in clinical studies is a challenging and specialised area of clinical trial supplies. In this case study, Almac...
HIGHLY POTENT TECHNICAL TRANSFER AND COMMERCIAL MANUFACTURING

Alkermes successful approach to commercial-scale, final dosage manufacture of drug product containing highly potent API for a global pharmaceutical company.

Alkermes | 17-Dec-2012 | PDF Case study
As part of Alkermes plc, Alkermes Contract Pharma Services, provides solid oral dosage product development, scale–up and manufacturing se...

Best Practices for Achieving and Maintaining Aseptic Conditions During Sterility Testing

SGS | 01-Jan-1970 | PDF Technical / white paper
Sterility testing is required for companies producing pharmaceutical products and consistent and meticulous testing is essential to obtai...

Analytical Method Development and Validation — A CDMO Perspective

DPT Labs | 20-Nov-2012 | PDF Insight guide
Pharmaceutical drug product development can be an expensive and time consuming process. Many challenges are faced by pharmaceutical devel...
Smaller pharma companies financially benefitting from CDMO partnerships

Smaller pharma companies financially benefitting from CDMO partnerships

Recipharm AB | 15-Nov-2012 | PDF Case study
In today’s global economy, available financing is increasingly scarce for pharmaceutical companies looking to bring new products to marke...
Baxter

Lyophilized Pharmaceuticals: A Design Space Approach

Baxter | 22-Oct-2012 | PDF Technical / white paper
This presentation by Steven Nail, PhD and principal Scientist for Baxter BioPharma Solutions, discusses development of design spaces for...

Extractables & Leachables Risk Assessment

SGS | 17-Oct-2012 | PDF Case study
An extractables and leachables case study describes how a comprehensive risk assessment was performed across the entire production proces...

Biosafety Testing: In Vitro Virus Detection

SGS | 03-Oct-2012 | PDF Technical / white paper
Regulatory authorities (US FDA and the EMEA) impose stringent limits on the amount of microbial contaminates and impurities present durin...

Identifying a Differentiated Product – 505(b)(2)

Camargo | 03-Oct-2012 | PDF Data sheet
With a generic cliff approaching, the 505(b)(2) development process can make changes to reference products for greater profit potential a...

Vetter – Answers that work

Vetter Pharma International GmbH | 13-Sep-2012 | PDF Data sheet
There are many sides to your product’s success. Build them together at Vetter.Whether your injectable is still at the starting line or in...

Identifying the Product

Camargo | 24-Sep-2012 | PDF Technical / white paper
With a generic cliff approaching, the 505(b)(2) development process can make changes to reference products for greater profit potential a...

Biomarkers of Toxicity Panel in Clinical Trials

ACM Global Central Laboratory | 13-Sep-2012 | PDF Technical / white paper
Most drug candidates are discontinued because of induced organ toxicity and half of them owe this to liver toxicity. This issue explains...

505(b)(2): Fast and Cost-Effective Drug Approval

Camargo | 03-Sep-2012 | PDF Data sheet
Looking to identify a new product for development or improve an existing compound? For lower risk, reduced cost and faster speed to marke...

New Early Phase Concepts: Practical Implementation

SGS | 03-Sep-2012 | PDF Technical / white paper
There is an urgent need to use innovative techniques in early development. This paper will discuss several case studies in which new clin...
Molecular Imaging Inc

Utility of FDG PET in Drug Development

Molecular Imaging Inc. | 01-Jan-1970 | PDF Technical / white paper
Imaging metabolism with FDG PET offers reliable and clinically translatable biomarkers for evaluation of candidate compounds.

Connecting Perfectly At Every Stage

Parexel | 16-Jul-2012 | PDF Data sheet
We believe in one bond that's more important than all others. Download our brochure to see how PAREXEL can help to optimize your product...
Enhanced Rheumatoid Arthritis CIA and CAIA Studies

Enhanced Rheumatoid Arthritis CIA and CAIA Studies

Molecular Imaging Inc. | 01-Jan-1970 | PDF Data sheet
Detect disease modification with biomarker imaging using PET, FMT & CT to assess treatment response. Enhance decision...

Vaccine-Based Clinical Trials

SGS | 06-Jul-2012 | PDF Technical / white paper
Download this paper to read two case studies which illustrate strategies for planning and implementing a vaccine-based infectious disease...
The new product development reality

The new product development reality

Parexel | 01-Jan-1970 | PDF Technical / white paper
While winning FDA or other regulatory approval is a formidable hurdle, it is no longer the end game when it comes to defining if the deve...

505(b)(2): Fast and Cost-Effective Drug Approval

Camargo | 15-Jun-2012 | PDF Data sheet
Looking to embark on a 505(b)(2) product approval?More products than ever are approved via the 505(b)(2) pathway — a fast and cost-effect...

Key Industry Events

 

Access all events listing

Our events, Events from partners...